The Alzheimer's Disease Assessment Scale-Cognitive-Plus (ADAS-Cog-Plus): An expansion of the ADAS-Cog to improve responsiveness in MCI

Brain Imaging and Behavior

Volumn 6, Issue 4, 2012, Pages 489-501

  Skinner, Jeannine ^a,f   Carvalho, Janessa O ^b   Potter, Guy G ^c   Thames, April ^d   Zelinski, Elizabeth ^e   Crane, Paul K ^a   Gibbons, Laura E ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

ADAS Cog; Alzheimer's disease biomarkers; Functional assessment; Mild cognitive impairment

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4; MEMBRANE PROTEIN; PHOSPHORYLATED TAU PROTEIN 181; TAU PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE ASSESSMENT SCALE COGNITIVE PLUS; ARTICLE; BRAIN SIZE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ASSESSMENT TOOL; DEMENTIA; DISEASE ASSOCIATION; EXECUTIVE FUNCTION; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; FUNCTIONAL STATUS; HUMAN; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHOLOGIC TEST;

EID: 84871713405     PISSN: 19317557     EISSN: 19317565     Source Type: Journal    
DOI: 10.1007/s11682-012-9166-3     Document Type: Article

References (41)

1. Baker, F. B., & Kim, S.-H. (2004). Item response theory: Parameter estimation techniques (2nd ed.). New York: CRC Press.
2. Beaton, D. E., Bombardier, C., Katz, J. N., & Wright, J. G. (2001). A taxonomy for responsiveness. Journal of Clinical Epidemiology, 54, 1204-1217.
3. Benge, J. F., Balsis, S., Geraci, L., Massman, P. J., & Doody, R. S. (2009). How well do the ADAS-Cog and its subscales measure cognitive dysfunction in Alzheimer's disease? Dementia and Geriatric Cognitive Disorders, 28(1), 63-69.
4. Birks, J., Grimley Evans, J., Iakovidou, V., Tsolaki, M., & Holt, F. E. (2009). Rivastigmine for Alzheimer's disease. Cochrane Database of Systematic Reviews, 15(2).
5. Brandt, J., Aretouli, E., Neijstrom, E., Samek, J., Manning, K., Albert, M. S., et al. (2009). Selectivity of executive function deficits in mild cognitive impairment. Neuropsychology, 23(5), 607-618.
6. Brown, P. J., Devanand, D. P., Liu, X., Caccappolo, E., & for the Alzheimer's Disease Neuroimaging Initiative. (2011). Functional impairment in elderly patients with mild cognitive impairment and mild Alzheimer disease. Archives of General Psychiatry, 68(6), 617-626.
7. Butt, Z. (2008). Sensitivity of the informant questionnaire on cognitive decline: an application of item response theory. Neuropsychology, Development, and Cognition. Section B Aging Neuropsychology Cognition, 15(5), 642-655.
8. Cahn-Weiner, D. A., Boyle, P. A., & Malloy, P. F. (2002). Tests of executive function predict instrumental activities of daily living in community-dwelling older individuals. Applied Neurology, 9(3), 187-191.
9. Connor, D. J., & Sabbagh, M. N. (2008). Administration and scoring variance on the ADAS-Cog. Journal of Alzheimer Disease, 15(3), 461-464.
10. Desikan, R. S., Ségonne, F., Fischl, B., Quinn, B. T., Dickerson, B. C., Blacker, R. L., et al. (2006). An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage, 31(3), 968-980.
11. Devanand, D. P., Pradhaban, G., Liu, X., Khandji, A., De Santi, S., Segal, S., et al. (2007). Hippocampal and entorhinal atrophy in MCI: prediction of Alzheimer disease. Neurology, 68(11), 828-836.
12. Evans, M. C., Barnes, J., Nielsen, C., Kim, L. G., Clegg, S. L., Blair, M., Leung, K. K., et al. (2010). Volume changes in Alzheimer's disease and mild cognitive impairment: cognitive associations. European Radiology, 20(3), 674-682.
13. Farias, S. T., Mungas, D., Reed, B. R., Harvey, D., Cahn-Weiner, D., & DeCarli, C. (2006). MCI is associated with deficits in everyday functioning. Alzheimer Disease and Associative Disorders, 20(4), 217-223.
14. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatry Research, 12(3), 189-198.
15. Griffith, H. R., Belue, K., Sicola, A., Krzywanski, S., Zamrini, E., Harrell, L., & Marson, D. C. (2003). Impaired financial abilities in mild cognitive impairment: A direct assessment approach. Neurology, 60(3), 449-457.
16. Husted, J. A., Cook, R. J., Farewell, V. T., & Gladman, D. D. (2000). Methods for assessing responsiveness: a critical review and recommendations. Journal of Clinical Epidemiology, 53(5), 459-468.
17. Ihl, R., Ferris, S., Robert, P., Winblad, B., Gauthier, S., & Tennigkeit, F. (2012). Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer's disease. International Journal of Geriatric Psychiatry, 27(1), 15-21.
18. Kirshner, B., & Guyatt, G. (1985). A methodological framework for assessing health indices. Journal of Chronic Disease, 38(1), 27-36.
19. Koss, E., Patterson, M. B., Ownby, R., Stuckey, J. C., & Whitehouse, P. J. (1993). Memory evaluation in Alzheimer's disease. Caregiver's appraisals and objective testing. Archives of Neurology, 50(1), 92-97.
20. Li, J., Wu, H. M., Zhou, R. L., Liu, G. J., & Dong, B. R. (2008). Huperzine A for Alzheimer's disease. Cochrane Database of Systematic Reviews, 16(2).
21. Llano, D. A., Laforet, G., & Devanarayan, V. (2011). Derivation of a new ADAS-Cog composite using tree-based multivariate analysis: prediction of conversion from mild cognitive impairment to Alzheimer disease. Alzheimer Disease & Associative Disorders, 25(1), 73-84.
22. Loveman, E., Green, C., Kirby, J., Takeda, A., Picot, J., Payne, E., & Clegg, A. (2006). The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease. Health Technology Assessment, 10(1), 1-160.
23. Mackinnon, A., Khalilian, A., Jorm, A. F., Korten, A. E., Christensen, H., & Mulligan, R. (2003). Improving screening accuracy for dementia in a community sample by augmenting cognitive testing with informant report. Journal of Clinical Epidemiology, 56(4), 358-366.
24. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadian, E. M. (1984). Clinical diagnosis of Alzheimer disease: report of the NINCDS-ADRDA work group under the auspices of department of health & human services task force on Alzheimer's disease. Neurology, 34(7), 939-944.
25. McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Jr., Kawas, C. H., Klunk, W. E., Koroshetsz, W. J., et al. (2011). The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia, 7(3), 263-269.
26. Mohs, R. C., Knopman, D., Petersen, R. C., Ferris, S. H., Ernesto, C., Grundman, M., et al. (1997). Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.Alzheimer Disease & Associative Disorders, 11(Suppl 2), S13-21.
27. Morris, J. C. (1993). The clinical dementia rating scale (CDR): current version and scoring rules. Neurology, 43(11), 2412-2414.
28. Muthén, L. K., & Muthén, B. O. (1998-2007). Mplus (Version 5. 1). Los Angeles: Author.
29. Nakata, E., Kasai, M., Kasuya, M., Akanuma, K., Meguro, M., Ishii, H., et al. (2009). Combined memory and executive function tests can screen mild cognitive impairment and converters to dementia in a community: the Osaki-Tajiri project. Neuroepidemiology, 33(2), 103-110.
30. Pfeffer, R. I., Kurosaki, T. T., Harrah, C. H., Jr., Chance, J. M., & Filos, S. (1982). Measurement of functional activities in older adults in the community. Journal of Gerontology, 37(3), 323-329.
31. Reeve, B. B., Hayes, R. D., Bjorner, J. B., Cook, K. F., Crane, P. K., et al. (2007). Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Medical Care, 45(5 Suppl 1), S22-31.
32. Reitan, R. M., & Wolfson, D. (1985). The Halstead-Reitan neuropsychological test battery: Theory and clinical interpretation. Tucson: Neuropsychology Press.
33. Rosen, W. G., Mohs, R. C., & Davis, K. L. (1984). A new rating scale for Alzheimer's disease. The American Journal of Psychiatry, 141(11), 1356-1364.
34. Rozzini, L., Chilovi, B. V., Conti, M., Bertoletti, E., Delrio, I., Trabucchi, M., & Padovani, A. (2007). Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration. International Journal of Geriatric Psychiatry, 22(12), 1217-1222.
35. Sabbagh, M. N., Malek-Ahmadi, M., Kataria, R., Belden, C. M., Connor, D. J., Pearson, C., et al. (2010). The Alzheimer's questionnaire: a proof of concept study for a new informant-based dementia assessment. Journal of Alzheimer's Disease, 22(3), 1015-1021.
36. Sano, M., Raman, R., Emond, J., Thomas, R. G., Petersen, R., Schneider, L. S., & Alsen, P. S. (2011). Adding delayed recall to the Alzheimer Disease Assessment Scale is useful in studies of mild cognitive impairment but not Alzheimer disease. Alzheimer Disease & Associative Disorders, 25(2), 122-127.
37. Shaw, L. M., Vanderstichele, H., Knapik-Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., et al. (2009). Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Annals of Neurology, 65(4), 403-413.
38. Strauss, E., Sherman, E., & Spreen, O. (Eds.). (2006). A compendium of neuropsychological test, administration, norms, and commentary (3rd ed.). Oxford: University Press.
39. Tomaszewski-Farias, S. T., Cahn-Weiner, D. A., Harvey, D. J., Reed, B. R., Mungas, D., Kramer, J. H., & Chui, H. (2009). Longitudinal changes in memory and executive function are associated with longitudinal change in instrumental activities of daily living in older adults. Clinical Neuropsychology, 23(3), 446-461.
40. Wechsler, D. (1987). Weschler adult intelligence scale-revised. San Antonio: The Psychological Cooperation.
41. Wouters, H., van Gool, W. A., Schmand, B., & Lindeboom, R. (2008). Revising the ADAS-Cog for a more accurate assessment of cognitive impairment. Alzheimer Disease and Associative Disorders, 22(3), 236-244.